These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8770849)

  • 1. Clinical studies with the new glycosylated recombinant prourokinase.
    Sasahara AA; Barker WM; Weaver WD; Hartmann J; Anderson JL; Reddy PS; Villiard EM
    J Vasc Interv Radiol; 1995; 6(6 Pt 2 Suppl):84S-93S. PubMed ID: 8770849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of prourokinase injection in patients with ST-elevation myocardial infarction: phase IV clinical trials of the prourokinase phase study.
    Zhao L; Zhao Z; Chen X; Li J; Liu J; Li G;
    Heart Vessels; 2018 May; 33(5):507-512. PubMed ID: 29209778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prourokinase versus urokinase for recanalization of peripheral occlusions, safety and efficacy: the PURPOSE trial.
    Ouriel K; Kandarpa K; Schuerr DM; Hultquist M; Hodkinson G; Wallin B
    J Vasc Interv Radiol; 1999 Sep; 10(8):1083-91. PubMed ID: 10496712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of dose regimens for the administration of recombinant pro-urokinase in a canine thrombosis model.
    Burke SE; Lubbers NL; Nelson RA; Henkin J
    Thromb Haemost; 1997 May; 77(5):1025-30. PubMed ID: 9184422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolytic mechanism, biochemistry, and preclinical pharmacology of recombinant prourokinase.
    Credo RB; Burke SE
    J Vasc Interv Radiol; 1995; 6(6 Pt 2 Suppl):8S-18S. PubMed ID: 8770836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New recombinant glycosylated prourokinase for treatment of patients with acute myocardial infarction. Prourokinase Study Group.
    Weaver WD; Hartmann JR; Anderson JL; Reddy PS; Sobolski JC; Sasahara AA
    J Am Coll Cardiol; 1994 Nov; 24(5):1242-8. PubMed ID: 7930246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.
    Furlan A; Higashida R; Wechsler L; Gent M; Rowley H; Kase C; Pessin M; Ahuja A; Callahan F; Clark WM; Silver F; Rivera F
    JAMA; 1999 Dec; 282(21):2003-11. PubMed ID: 10591382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pro-urokinase for infarct therapy].
    Spiecker M; Meyer J
    Herz; 1994 Dec; 19(6):326-35. PubMed ID: 7843689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile of recombinant pro-urokinase given by intraarterial versus intravenous routes of administration in a canine thrombosis model.
    Burke SE; Lubbers NL; Nelson RA; Wegner CD; Cox BF
    Thromb Haemost; 1999 Feb; 81(2):301-5. PubMed ID: 10064010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of intravenous prourokinase and a combination of prourokinase and urokinase in acute myocardial infarction.
    Bode C; Schoenermark S; Schuler G; Zimmermann R; Schwarz F; Kuebler W
    Am J Cardiol; 1988 May; 61(13):971-4. PubMed ID: 2452564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial.
    Kase CS; Furlan AJ; Wechsler LR; Higashida RT; Rowley HA; Hart RG; Molinari GF; Frederick LS; Roberts HC; Gebel JM; Sila CA; Schulz GA; Roberts RS; Gent M
    Neurology; 2001 Nov; 57(9):1603-10. PubMed ID: 11706099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dose urokinase preactivated natural prourokinase for thrombolysis in acute myocardial infarction.
    Gulba DC; Fischer K; Barthels M; Polensky U; Reil GH; Daniel WG; Welzel D; Lichtlen PR
    Am J Cardiol; 1989 May; 63(15):1025-31. PubMed ID: 2495709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose finding with a novel recombinant plasminogen activator (BM 06.022) in patients with acute myocardial infarction: results of the German Recombinant Plasminogen Activator Study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK).
    Neuhaus KL; von Essen R; Vogt A; Tebbe U; Rustige J; Wagner HJ; Appel KF; Stienen U; König R; Meyer-Sabellek W
    J Am Coll Cardiol; 1994 Jul; 24(1):55-60. PubMed ID: 8006283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of pharmacoinvasive therapy with prourokinase for acute ST-segment elevation myocardial infarction patients with expected long percutaneous coronary intervention-related delay.
    Han YL; Liu JN; Jing QM; Ma YY; Jiang TM; Pu K; Zhao RP; Zhao X; Liu HW; Xu K; Wang G; Wang B; Sun RH; Wang J
    Cardiovasc Ther; 2013 Oct; 31(5):285-90. PubMed ID: 23634911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prourokinase mutant that induces highly effective clot lysis without interfering with hemostasis.
    Liu JN; Liu JX; Liu Bf BF; Sun Z; Zuo JL; Zhang Px PX; Zhang J; Chen Yh YH; Gurewich V
    Circ Res; 2002 Apr; 90(7):757-63. PubMed ID: 11964367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study). Liquemin in Myocardial Infarction During Thrombolysis With Saruplase.
    Tebbe U; Windeler J; Boesl I; Hoffmann H; Wojcik J; Ashmawy M; Rüdiger Schwarz E; von Loewis P; Rosemeyer P; Hopkins G
    J Am Coll Cardiol; 1995 Aug; 26(2):365-73. PubMed ID: 7608436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New substances and dosages for thrombolysis in acute myocardial infarct].
    Zeymer U; Neuhaus KL
    Z Kardiol; 1993; 82 Suppl 2():137-41. PubMed ID: 8328192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of taprostene in patients with acute myocardial infarction treated with thrombolytic therapy: results of the START study. Saruplase Taprostene Acute Reocclusion Trial.
    Bär FW; Meyer J; Michels R; Uebis R; Lange S; Barth H; Groves R; Vermeer F
    Eur Heart J; 1993 Aug; 14(8):1118-26. PubMed ID: 8404943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant single-chain urokinase-type plasminogen activator during acute myocardial infarction.
    Diefenbach C; Erbel R; Pop T; Mathey D; Schofer J; Hamm C; Ostermann H; Schmitz-Hübner U; Bleifeld W; Meyer J
    Am J Cardiol; 1988 May; 61(13):966-70. PubMed ID: 2452563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.